Introduction
============

ST segment elevation myocardial infarction (STEMI) is a major health problem whose rate increases with increasing age in both sexes. Primary percutaneous coronary intervention (PPCI) is an urgent angiographic strategy following angioplasty with or without stenting. It is accepted as the preferred reperfusion strategy performed in many cases with STEMI.[@b1-ARYA-09-134]

The thrombolysis in myocardial infarction (TIMI) flow grading system is a qualitative method for measuring reperfusion strategy. On the other hand, the corrected TIMI frame count (CTFC) is a quantitative method to assess the TIMI flow grading system. It is simply performed by counting the number of angiographic frames elapsed until the contrast material arrives in the distal bed of the vessel of interest. The mean CTFC of normal coronary arteries has been reported as 21.1 ± 1.5 for left anterior descending artery (LAD), 22.2 ± 4.4 for left circumflex artery (LCX), and 20.4 ± 3.3 for right coronary artery (RCA).[@b1-ARYA-09-134],[@b2-ARYA-09-134] CTFC is an independent predictor of in-hospital mortality following STEMI.[@b3-ARYA-09-134]-[@b6-ARYA-09-134]

The objective of this study was to evaluate the associations between CTFC and ejection fraction (EF) soon after PPCI and three-six months later in patients with STEMI. As EF is a known predictor of early and late survival, the findings of the current study may enable cardiologists to better predict cardiovascular outcomes following PPCI in patients with STEMI.

Materials and Methods
=====================

In 2009, this prospective study was conducted on patients who had received PPCI within 12 hours from the diagnosis of STEMI. Overall, 78 patients, including 66 (84.6%) men and 12 (15.4%) women, were included. STEMI was defined as typical chest pain and the presence of electrocardiographic criteria.[@b7-ARYA-09-134] Patients who had undergone rescue percutaneous coronary intervention (PCI) or late PCI were not included.

A checklist about cardiovascular risk factors, physical examination on admission, door- to-balloon time, systolic blood pressure, location of myocardial infarction (MI), TIMI flow grade, CTFC, ST resolution, EF (upon discharge and after three-six months), and in-hospital adverse events was filled out for all patients. Door-to-balloon time was defined as the interval between arrival to the hospital and the use of a therapeutic device (thrombectomy catheter, balloon, and stent).

All patients received 325 mg of aspirin, 300-600 mg of clopidogrel, and 40 mg of atorvastatin. PPCI was performed in the presence of reduced TIMI flow grade (\< 3), occluded infarct-related artery, and/or a culprit lesion stenosis of \> 50%. The use of glycoprotein IIb/IIIa inhibitors, thrombectomy and bare-metal or drug-eluting stents was left to the decision of the interventionalist.

Angiography CDs of the patients were reviewed by two interventional cardiologists and TIMI frame count (TFC) was measured by a digital system in the catheterization laboratory. TFC is the number of cine-frames required for contrast to reach a standardized distal coronary landmark in the culprit vessel and was determined by a previously suggested method.[@b3-ARYA-09-134],[@b8-ARYA-09-134] The first frame was selected when the column of the contrast extended across \> 70% of the arterial lumen with antegrade flow.[@b9-ARYA-09-134] The reported number was based on a cine filming rate of 30 frames per second. The last frame is a distal landmark to which the contrast enters. Distal landmark in the RCA is the first branch of the posterolateral extension of the RCA after the origin of the posterior descending artery. In the circumflex artery, it is the most distal branch of the obtuse marginal branch which included the culprit lesion. In the left anterior descending artery, it is a distal bifurcation which is usually placed at the apex of the heart. CTFC means that the TFC for LAD must be corrected by dividing it into 1.7 due to the longer length of the LAD.

Electrocardiograms were recorded on arrival and 60 minutes after the angioplasty. ST resolution was measured 60 minutes after PPCI at the corresponding lead with maximal ST elevation in pre-PCI echocardiography.

Patients were requested to come back to the hospital three-six months later for the second echocardiography. Patients' EF was measured with biplane Simpson's method upon discharge and after three-six months. Standard medical treatment comprised aspirin, clopidogrel, beta-blockers, atorvastatin, and enalapril/losartan for all patients.

Baseline characteristics were expressed as mean ± standard deviation (SD) or percentages. Continuous variables were compared by the Student\'s t-test. Categorical variables were contrasted by the chi-square test (or Fisher\'s exact test as needed). All analyses were performed with SPSS for Windows 16.0 (SPSS Inc., Chicago, IL, USA). P values less than 0.05 were considered significant.

Results
=======

The patients were divided into two groups of CTFC ≤ 20 and CTFC \> 20. [Table 1](#t1-ARYA-09-134){ref-type="table"} presents baseline characteristics of the studied population stratified by CTFC. There was not any significant difference between the two CTFC groups regarding baseline characteristics.

[Table 2](#t2-ARYA-09-134){ref-type="table"} compares the clinical characteristics of the patients. The mean door-to-balloon time in the groups with CTFC ≤ 20 and CTFC \> 20 was 45.1 ± 16.8 and 44.6 ± 11.8 minutes, respectively (P = 0.879). The mean systolic blood pressure/mean diastolic blood pressure in the mentioned groups was 118.5 ± 20.2/72.3 ± 12.0 and 113.7 ± 22.4/69.6 ± 10.8 mmHg, respectively (P \> 0.05). Less than 10% of the patients in every group had signs of heart failure at presentation. Moreover, there was no significant differences between the two CTFC groups regarding clinical characteristics.

The two CTFC groups were similar in the administration of aspirin, clopidogrel, heparin, glycoprotein IIb/IIIa inhibitors, and atorvastatin. According to angiography results, in the groups with CTFC ≤ 20 and CTFC \> 20, 16.7% and 4.2% of patients had single vessel disease (SVD), 57.4% and 41.7% had two-vessel disease (2VD), and 25.9% and 54.2% had three-vessel disease (3VD), respectively. Number of narrowed coronary arteries in the two groups did not have a significant difference (P = 0.036). Furthermore, stenotic lesions in the LAD were detected in 87.0% and 37.5% of the groups with CTFC ≤ 20 and CTFC \> 20, respectively. The corresponding rates of stenotic lesions in the LCX were 1.9% and 25.0%. Stenotic lesions in the RCA were also found in 11.1% of patients with CTFC ≤ 20 and 37.5% of patients with CTFC \> 20 (P \< 0.001 for all). The most infarcted arteries were LAD in patients with CTFC ≤ 20 and both LAD and RCA in patients with CTFC \> 20. The two groups had a significant difference in pre-PCI TIMI flow grade (P = 0.006) ([Table 3](#t3-ARYA-09-134){ref-type="table"}).

Stenting was performed for all patients in the group with CTFC ≤ 20. In the other group, however, two subjects (8.3%) underwent balloon angioplasty without stenting. Drug-eluting stents were used for 48.1% of the patients in the group with CTFC ≤ 20 and for 12.5% of other patients (P \< 0.001). Two patients (3.7%) in the group with CTFC ≤ 20 and two (8.3%) in the group with CTFC \> 20 had no ST resolution (P = 0.583) ([Table 3](#t3-ARYA-09-134){ref-type="table"}).

The use of the intra-aortic balloon pump and thrombectomy devices was low in both groups and without a significant difference. Acute in-stent thrombosis occurred in one patient who underwent coronary artery bypass graft surgery. The rate of cardiogenic shock and death were 5.6% and 3.7% in the group with CTFC ≤ 20, respectively. The corresponding values in the group with CTFC \> 20 were 0% and 0%, respectively. No significant differences were identified between the two groups (P \> 0.05) ([Table 3](#t3-ARYA-09-134){ref-type="table"}).

[Table 4](#t4-ARYA-09-134){ref-type="table"} compares CTFC and EF before discharge and after three months of treatment. No significant difference was observed for EF at discharge between the two CTFC groups (P \> 0.05). However, the two groups significantly differed in EF after three-six months. After three-six months, the mean EF was 49.6% ± 8.7% and 41.6% ± 12.4% in patients with CTFC ≤ 20 and CTFC \> 20, respectively (P = 0.007).

Discussion
==========

According to the obtained results, lower CTFC was associated with higher EF after three-six months. CTFC is a quantitative and reproducible method for assessment of infarct-related artery flow. EF is the most powerful determinant of survival. We measured EF a few months after MI when myocardial stunning was likely to resolve.

Research has shown lower CTFC of the infarct-related artery immediately after PCI to be associated with better improvement in left ventricular function.[@b10-ARYA-09-134],[@b11-ARYA-09-134] CTFC also has a significant correlation with wall motion score index.[@b10-ARYA-09-134] Gibson et al. suggested higher CTFC 90 minutes after thrombolytic therapy to be linked with higher adverse outcomes.[@b11-ARYA-09-134] In another study, Gibson et al. reported that patients with acute coronary syndrome who died after PCI had a higher CTFC compared to those who survived.[@b12-ARYA-09-134] On the other hand, some studies have failed to identify any relations between CTFC and adverse clinical outcomes or functional recovery after thrombolytic therapy.[@b13-ARYA-09-134],[@b14-ARYA-09-134]

French et al. found a significant correlation between CTFC and three-week survival after MI. They concluded that CTFC ≥ 40 is a predictor of adverse outcomes including mortality, 30-day in-hospital major adverse cardiac events, reinfarction, congestive heart failure, and left ventricular remodeling.[@b6-ARYA-09-134] Gibson et al. detected a weak correlation between CTFC and radionuclide left ventricular EF measured through ventriculography.[@b11-ARYA-09-134]

In this study, baseline and clinical characteristics were similar to recently published studies in the field of MI. Like the finding of Nielsen et al. door-to-balloon time was short.[@b15-ARYA-09-134] Success rate of primary PCI was high, and the presence of CTFC ≤ 20 immediately after PPCI could be a predicator of high EF in patients with STEMI three months after the procedure.

Study limitations

There are several limitations in the current study. First, the number of patients was relatively small. Second, patients referred for primary PCI might have had different LAD length; and a factor of 1.7 to correct the TFC for all of them is not perfect.[@b9-ARYA-09-134] Third, the follow-up period was short and hence further studies with longer follow-up are recommended. This allows for better understanding of the role of CTFC in predicting EF and prognosis of patients who undergo PPCI for STEMI.

Conclusion

Lower CTFC of infarct-related artery is associated with better EF after a few months in patients who receive PPCI for STEMI. Post-PPCI CTFC may be an independent predictor of clinical and functional outcome and can thus provide better risk assessment and triage in such patients.
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###### 

Baseline characteristics of patients with ST segment elevation myocardial infarction stratified by post-primary percutaneous coronary intervention (PCI) corrected thrombolysis in myocardial infarction frame count (CTFC)

  Variables                                  Total        Post-PCI CTFC   P            
  ------------------------------------------ ------------ --------------- ------------ -------
  Number                                     78           54              24           \-
  Age (years; mean ± SD)                     58.7 ± 9.2   58.2 ± 9.3      59.9 ± 9.1   0.451
  Gender (female)                            12 (15.4)    10 (18.5)       2 (8.3)      0.324
  Obesity                                    19 (24.4)    15 (27.8)       4 (16.7)     0.395
  Family history ofcoronary artery disease   10 (12.8)    7 (13)          3 (12.5)     1.000
  Smoker                                     34 (43.6)    21 (38.9)       13 (54.2)    0.227
  Hypertension                               29 (37.2)    19 (35.2)       10 (41.7)    0.619
  Hyperlipidemia                             27 (34.6)    15 (27.8)       12 (50.0)    0.073
  Diabetes mellitus                          24 (30.8)    14 (25.9)       10 (41.7)    0.191
  Chronic lung disease                       0 (0.0)      0 (0.0)         0 (0.0)      \-
  Cerebrovascular disease                    0 (0.0)      0 (0.0)         0 (0.0)      \-
  Peripheral vasculardisease                 0 (0.0)      0 (0.0)         0 (0.0)      \-
  Previous congestiveheart failure           0 (0.0)      0 (0.0)         0 (0.0)      \-
  Previous myocardialinfarction              4 (5.1)      2 (3.7)         2 (8.3)      0.583
  Previous PCI                               5 (6.4)      4 (7.4)         1 (4.2)      1.000
  Previous coronaryartery bypass grafting    0 (0.0)      0 (0.0)         0 (0.0)      \-
  Creatinine (mg/dL; mean± SD)               1.2 ± 0.3    1.2 ± 0.3       1.2 ± 0.3    0.662

Values are presented as n (%) unless otherwise expressed.

###### 

Clinical and medicine-related characteristics of patients with ST segment elevation myocardial infarction stratified by post-primary percutaneous coronary intervention (PCI) corrected thrombolysis in myocardial infarction frame count (CTFC)

  Variables                                   Total                               Post-PCI CTFC   P                            
  ------------------------------------------- ----------------------------------- --------------- -------------- ------------- -------
  Door-to-balloontime (minutes; mean ± SD)    44.9 ± 15.4                         45.1 ± 16.8     44.6 ± 11.8    0.879         
  Door-to-balloontime ≥ 60 minutes            5 (6.4)                             3 (5.5)         2 (8.3)        \-            
  Door-to-balloontime ≥ 90 minutes            0 (0.0)                             0 (0.0)         0 (0.0)        \-            
  Systolic bloodpressure (mmHg; mean ± SD)    117.0 ± 20.9                        118.5 ± 20.2    113.7 ± 22.4   0.377         
  Diastolic bloodpressure (mmHg; mean ± SD)   71.5 ± 11.6                         72.3 ± 12.0     69.6 ± 10.8    0.325         
  Signs of heartfailure at presentation                                                                                        
                                               S3                                 4 (5.1)         2 (3.7)        2 (8.3)       0.583
                                               No rales                           69 (88.5)       48 (88.9)      21 (87.5)     0.067
                                               Rales up to 1/3                    7 (9.0)         6 (11.1)       1 (4.2)       
                                               Rales more than 1/3                2 (2.6)         0 (0.0)        2 (8.3)       
  Cardiac markers(mean ± SD)                                                                                                   
                                               Troponin (ng/ml)                   12.7 ± 9.4      13.8 ± 9.6     10.3 ± 8.7    0.118
                                               Creatine phosphokinase (U/l)       3711 ± 3706     3603 ± 2859    3955 ± 5202   0.757
                                               Creatine kinase MB (U/l)           370 ± 386       406 ± 440      288 ± 209     0.114
  Drugs                                                                                                                        
                                               Aspirin                            24 (100)        24 (100)       24 (100)      \-
                                               Clopidogrel                        24 (100)        24 (100)       24 (100)      \-
                                               Unfractionated heparin             24 (100)        24 (100)       24 (100)      \-
                                               Glycoprotein IIb/IIIa inhibitors   63 (80.8)       44 (81.5)      19 (79.2)     1.000
                                               Integrilin                         60 (76.9)       42 (77.0)      18 (75.0)     0.928
                                               Tirofiban                          3 (3.8)         2 (3.7)        1 (4.2)       1.000
                                               Statin                             78 (100)        54 (100)       24 (100)      \-

Values are presented as n (%) unless otherwise expressed.

SD: Standard deviation.

###### 

Incidence of events in patients with ST segment elevation myocardial infarction stratified by post-primary percutaneous coronary intervention (PCI) corrected thrombolysis in myocardial infarction frame count (CTFC)

  Variables                                               Overall                            Post-PCI CTFC   P                         
  ------------------------------------------------------- ---------------------------------- --------------- ------------ ------------ ----------
  Number of narrowed coronary arteries                                                                                                 
                                                           1                                 10 (12.8)       9 (16.7)     1 (4.2)      0.036
                                                           2                                 41 (52.6)       31 (57.4)    10 (41.7)    
                                                           3                                 27 (34.6)       14 (25.9)    13 (54.2)    
  Infarct-related artery                                                                                                               
                                                           Left main                         0 (0.0)         0 (0.0)      0 (0.0)      \< 0.001
                                                           Left anteriordescending           56 (71.8)       47 (87.0)    9 (37.5)     
                                                           Left circumflex                   7 (9.0)         1 (1.9)      6 (25.0)     
                                                           Right coronaryartery              15 (19.2)       6 (11.1)     9 (37.5)     
                                                           Saphenous vein graft              0 (0.0)         0 (0.0)      0 (0.0)      
  Pre-PCI TIMI flow grade of the infarct-related artery                                                                                
                                                           0                                 53 (67.9)       38 (70.4)    15 (62.5)    0.006
                                                           1                                 8 (10.3)        8 (14.8)     0 (0.0)      
                                                           2                                 14 (17.9)       5 (9.3)      9 (37.5)     
                                                           3                                 3 (3.8)         3 (5.6)      0 (0.0)      
  Stent implantation                                                                                                                   
                                                           No stents                         2 (2.6)         0 (0.0)      2 (8.3)      0.067
                                                           One stent                         66 (84.6)       48 (88.9)    18 (75.0)    
                                                           Two stents                        9 (11.5)        6 (11.1)     3 (12.5)     
                                                           Three stents                      1 (1.3)         0 (0.0)      1 (4.2)      
                                                          Drug eluting stent                 29 (37.2)       26 (48.1)    3 (12.5)     \< 0.001
                                                          Stent diameter (mm; mean ± SD)     2.9 ± 0.3       2.9 ± 0.3    2.8 ± 0.3    0.474
                                                          Stent length (mm; mean ± SD)       24.7 ± 5.3      25.7 ± 5.0   22.0 ± 5.3   0.007
                                                          Intra-aortic balloon pump          3 (3.8)         2 (1.9)      1 (8.3)      0.223
                                                          Thrombectomy                       3 (3.8)         1 (1.9)      2 (8.3)      0.223
                                                          Stent thrombosis                   1 (1.3)         1 (1.9)      0 (0.0)      1.000
                                                          Cardiogenic shock                  3 (3.8)         3 (5.6)      0 (0.0)      0.549
                                                          No ST resolution                   4 (5.1)         2 (3.7)      2 (8.3)      0.583
  In-hospital events                                                                                                                   
                                                           Major bleeding                    0 (0.0)         0 (0.0)      0 (0.0)      \-
                                                           Stroke/transientischemic attack   0 (0.0)         0 (0.0)      0 (0.0)      \-
                                                           Dialysis                          2 (2.6)         0 (0.0)      2 (8.3)      \> 0.05
                                                           Death                             2 (2.6)         2 (3.7)      0 (0.0)      1.000

Values are presented as n (%) unless otherwise expressed.

SD: Standard deviation.

###### 

Post-primary percutaneous coronary intervention (PCI) corrected thrombolysis in myocardial infarction frame count (CTFC) and ejection fraction (EF) before discharge and three months after discharge

  Variables                              Overall       Post-PCI CTFC   P             
  -------------------------------------- ------------- --------------- ------------- ----------
  EF before discharge (%; mean ± SD)     42.5 ± 10.5   42.1 ± 10.2     43.5 ± 11.4   0.611
  EF after three months (%; mean ± SD)   47.1 ± 10.6   49.6 ± 8.7      41.6 ± 12.4   0.007
  EF ≥ 50% before discharge              29 (37.2)     18 (33.3)       11 (45.8)     0.319
  EF ≥ 50% after three months            44 (57.9)     34 (65.4)       10 (41.7)     0.079
  EF change (%; mean ± SD)               4.2 ± 8.9     7.0 ± 8.3       -1.9 ± 6.9    \< 0.001

Values are presented as n (%) unless otherwise expressed.

SD: Standard deviation.
